Showing results (251-260 of 626) with videos related to
Sort By:
Pageof 63
The International Journal of Risk & Safety in Medicine|February 11, 2022
Beyond the garden: The complexity of "global and individual living" at the heart of the international commitment towards a healthy, more resilient and fairer societyLuca DimasiThe International Journal of Risk & Safety in Medicine|February 11, 2022
Gender medicine as a tool for implementing the right to healthFrancesca RescignoThe International Journal of Risk & Safety in Medicine|November 1, 2021
Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression studyNatalie Aboustate, Jon JureidiniThe International Journal of Risk & Safety in Medicine|October 10, 2019
Impact of increased focus on pharmacovigilance on knowledge and attitude towards adverse drug reaction reporting among medical students in IndiaJatinder Katyal, Ekta Arora, Yogendra Kumar GuptaThe International Journal of Risk & Safety in Medicine|March 11, 2022
Viruses without borders and the medical research agendaJacob StegengaThe International Journal of Risk & Safety in Medicine|March 11, 2022
The social organization of science during the COVID-19 pandemicManuela Fernández PintoThe International Journal of Risk & Safety in Medicine|July 1, 2019
Knowledge, attitudes and practice preference regarding drug prescriptions of resident dental doctors: A quantitative studyAnuj Chhabra, C Nidhi, Anurag JainThe International Journal of Risk & Safety in Medicine|September 1, 2012
Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medicationsRichard P Paczynski, G Caleb Alexander, Vernon M Chinchilli, et al.The International Journal of Risk & Safety in Medicine|May 8, 2023
A comparison of opioid prescription trends in England and the United States from 2008 to 2020Thurstan Moncrieff, Joanna MoncrieffThe International Journal of Risk & Safety in Medicine|July 4, 2012
The rosiglitazone decision process at FDA and EMA. What should we learn?Koen B Pouwels, Kees van GrootheestPageof 63